Maximus (MMS) Earning Somewhat Positive Media Coverage, Analysis Shows
Press coverage about Maximus (NYSE:MMS) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Maximus earned a media sentiment score of 0.05 on Accern’s scale. Accern also gave media stories about the health services provider an impact score of 44.3997630436656 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
These are some of the media stories that may have impacted Accern Sentiment Analysis’s scoring:
- Financial Survey: Maximus (MMS) versus G&K Services (GK) (americanbankingnews.com)
- Everi Holdings (EVRI) versus Maximus (MMS) Financial Survey (americanbankingnews.com)
- MAXIMUS to Present at the Western Interstate Child Support Enforcement Council Annual Conference (finance.yahoo.com)
- The MAXIMUS Foundation Pledges $100,000 to Support Hurricane Irma Disaster Recovery Efforts (finance.yahoo.com)
Several brokerages have recently issued reports on MMS. Zacks Investment Research downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Wednesday, August 9th. Maxim Group set a $66.00 price objective on shares of Maximus and gave the stock a “hold” rating in a research report on Thursday, August 3rd. BidaskClub downgraded shares of Maximus from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Robert W. Baird reissued a “hold” rating and set a $64.00 price objective on shares of Maximus in a research report on Friday, September 1st. Finally, Canaccord Genuity downgraded shares of Maximus from a “buy” rating to a “hold” rating and set a $62.00 price objective for the company. in a research report on Tuesday, July 4th. One research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $62.43.
Maximus (NYSE:MMS) opened at 65.06 on Thursday. Maximus has a one year low of $43.69 and a one year high of $65.37. The firm has a market cap of $4.22 billion, a PE ratio of 20.85 and a beta of 1.37. The company’s 50-day moving average is $60.88 and its 200 day moving average is $61.50.
Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.03. The business had revenue of $600.40 million during the quarter, compared to analyst estimates of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. Maximus’s quarterly revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.79 EPS. Equities analysts anticipate that Maximus will post $3.13 earnings per share for the current year.
The company also recently announced a quarterly dividend, which was paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th were paid a $0.045 dividend. The ex-dividend date was Friday, August 11th. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. Maximus’s payout ratio is 5.73%.
In other news, President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $63.28, for a total value of $506,240.00. Following the completion of the sale, the president now owns 35,904 shares in the company, valued at approximately $2,272,005.12. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel David Francis sold 1,000 shares of the company’s stock in a transaction on Friday, July 14th. The stock was sold at an average price of $60.46, for a total transaction of $60,460.00. Following the completion of the sale, the general counsel now owns 15,715 shares of the company’s stock, valued at approximately $950,128.90. The disclosure for this sale can be found here. In the last quarter, insiders sold 132,403 shares of company stock valued at $8,088,341. Company insiders own 3.10% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Maximus (MMS) Earning Somewhat Positive Media Coverage, Analysis Shows” was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another website, it was illegally stolen and republished in violation of US and international copyright laws. The legal version of this story can be accessed at https://www.thecerbatgem.com/2017/09/28/maximus-mms-earning-somewhat-positive-media-coverage-analysis-shows.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Stock Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related stocks with our FREE daily email newsletter.